0001104659-23-119331.txt : 20231117
0001104659-23-119331.hdr.sgml : 20231117
20231117092723
ACCESSION NUMBER: 0001104659-23-119331
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231115
FILED AS OF DATE: 20231117
DATE AS OF CHANGE: 20231117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rubric Capital Management LP
CENTRAL INDEX KEY: 0001687509
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-00100
FILM NUMBER: 231416748
BUSINESS ADDRESS:
STREET 1: 155 EAST 44TH ST, SUITE 1630
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 2124181881
MAIL ADDRESS:
STREET 1: 155 EAST 44TH ST, SUITE 1630
CITY: NEW YORK
STATE: NY
ZIP: 10017
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rosen David Efraim
CENTRAL INDEX KEY: 0001898677
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-00100
FILM NUMBER: 231416747
MAIL ADDRESS:
STREET 1: 155 EAST 44TH ST., SUITE 1630
CITY: NEW YORK
STATE: NY
ZIP: 10017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TherapeuticsMD, Inc.
CENTRAL INDEX KEY: 0000025743
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 870233535
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 951 YAMATO ROAD, SUITE 220
CITY: BOCA RATON
STATE: FL
ZIP: 33431
BUSINESS PHONE: 561-961-1900
MAIL ADDRESS:
STREET 1: 951 YAMATO ROAD, SUITE 220
CITY: BOCA RATON
STATE: FL
ZIP: 33431
FORMER COMPANY:
FORMER CONFORMED NAME: AMHN, Inc.
DATE OF NAME CHANGE: 20090930
FORMER COMPANY:
FORMER CONFORMED NAME: CROFF ENTERPRISES INC
DATE OF NAME CHANGE: 19970915
FORMER COMPANY:
FORMER CONFORMED NAME: CROFF OIL CO
DATE OF NAME CHANGE: 19920703
4
1
tm2330971-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-11-15
0
0000025743
TherapeuticsMD, Inc.
TXMD
0001687509
Rubric Capital Management LP
155 EAST 44TH ST, SUITE 1630
NEW YORK
NY
10017
1
0
1
1
See Remarks.
0001898677
Rosen David Efraim
155 EAST 44TH ST., SUITE 1630
NEW YORK
NY
10017
0
0
1
0
0
Common Stock, par value $0.001 per share ("Common Stock")
2023-11-15
4
A
0
877192
2.28
A
2946908
I
See footnote
The Common Stock was purchased in connection with a Subscription Agreement entered into as of May 1, 2023 between the Issuer and Rubric Capital, as described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 5, 2023.
This Form 4 is filed by Rubric Capital Management LP ("Rubric Capital") and Mr. David Rosen, with respect to the securities held by certain funds and/or accounts (collectively, the "Rubric Vehicles"). Rubric Capital serves as the investment adviser to the Rubric Vehicles. Mr. David Rosen serves as the Managing Member of Rubric Capital Management GP, LLC, the general partner of Rubric Capital. The filing of this statement shall not be deemed an admission that any Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each Reporting Person expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.
The Reporting Persons are directors by deputization for purposes of Section 16 under the Securities Exchange Act of 1934, as amended, by virtue of the fact that Justin Roberts, a Partner at Rubric Capital, serves on the board of directors of the Issuer.
Rubric Capital Management LP, By: /s/ Michael Nachmani, its Chief Operating Officer
2023-11-15
/s/ David Rosen its Chief Operating Officer
2023-11-15